 |
|
 |
 |
| THE
SAFE 'N SEXY, SLIM - DRUG, IONAMIN |
|
You know the type. At first when you meet them they
seem "safe". Obviously, they're always sexy. But, I'm
not referring to a man. Women who completed a market research
survey compared the appetite suppressant, Ionamin to a
man.
The super-pill for weight loss, Ionamin is not intended
for women only, But females find something irresistible
about the yellow-tan colored pill. Maybe it has something
to do with the pronunciation of the drug:
I - on - a - men.
Regardless of the stilted female bias, Ionamin produces
results. Ionamin is considered a sympathomimetic appetite
suppressants, the short-term remedy for obesity. The appetite-reducing
effect tends to decrease after a several weeks of use.
The objective of this type of diet aid is to jump start
your weight loss plan while you learn new ways to eat
and exercise.
Ionamin is similar to a new relationship. When you first
start dating someone, you're giddy and excited. The same
way you feel when you start losing weight. You feel sexier
about yourself because someone is attracted to you. I-ON-A-MIN
makes you feel sexy because you immediately feel the new
improved you trying to breakthrough.
As a member of the Phentermine family, Ionamin is a "resin".
When Ionamin was compared to it's family members, it was
determined that Ionamin did not put in a hard day's work.
In other words, the prescription is not as potent as Adipex
and the generic brand of Phentermine. Factually, Ionamin
worked longer hours but not as strenuous as the other
weight loss medications. So is Ionamin similar to a man?
Yes, and only if the man you're referring to has stamina
and paces his work throughout the day. That is just the
way Ionamin works measured throughout the day.
In the safety department, Ionamin is no different than
any other prescription with mild side effects. And any
drug that can offer you safety, make you feel sexy while
you lose weight -- is better than a man? Ionamin is the
safe, sexy, slim drug. |
|
HOME
| GO BACK |
|
 |
 |
 |
|
 |
 |